-
公开(公告)号:MX2011006333A
公开(公告)日:2011-06-27
申请号:MX2011006333
申请日:2009-12-22
Applicant: ABBOTT LAB
Inventor: DONNER PAMELA L , RANDOLPH JOHN T , DEGOEY DAVID A , KRUEGER ALLAN C , HUTCHINS CHARLES W , MOTTER CHRISTOPHER E , PILOT-MATIAS TAMI J , KATI WARREN M , NELSON LISSA T , PATEL SACHIN V , SOLTWEDEL TODD N , KRISHNAN PREETHI , MISTRY NEETA C , LI XIAOYAN
IPC: C07D471/04 , A61K31/4375 , A61K31/519 , A61P31/14
Abstract: Se describen compuestos efectivos para inhibir la réplica de virus de Hepatitis C ("HCV"). La presente invención también se refiere a procesos para elaborar dichos compuestos, composiciones que comprenden dichos compuestos, y métodos para utilizar dichos compuestos, para tratar infección HCV.
-
公开(公告)号:NZ552276A
公开(公告)日:2011-03-31
申请号:NZ55227605
申请日:2005-06-29
Applicant: ABBOTT LAB
Inventor: DEGOEY DAVID A , FLOSI WILLIAM J , GRAMPOVNIK DAVID J , KLEIN LARRY L , KEMPF DALE J , WANG XIU C
IPC: A61K31/661 , A61P35/00 , C07F9/09
Abstract: Disclosed are phosphor-ester prodrugs having formula (I), (II) or (III) where A is the substituent (i) and the rest of the variables are as disclosed in the description. Also disclosed are processes for making prodrugs of formula (I); pharmeacutical composistions containing a prodrug having formula (I), (II), or (III) and the use of a prodrug of formula (I), (II) or (III) in the preparation of a medicament for inhibiting HIV protease, for treating HIV infection, for improving the pharmacokinetics of a drug or for increasing human blood levels of a drug.
-
公开(公告)号:MX2010002905A
公开(公告)日:2010-07-05
申请号:MX2010002905
申请日:2008-09-17
Applicant: ABBOTT LAB
Inventor: BARNES DAVID M , PRATT JOHN K , BETEBENNER DAVID A , DONNER PAMELA L , MARING CLARENCE J , WAGNER ROLF , RANDOLPH JOHN T , DEGOEY DAVID A , FLENTGE CHARLES A , HUANG PEGGY P , HUTCHINSON DOUGLAS K , KRUEGER ALLAN C , HENRY RODGER F , KOTECKI BRIAN J , HAIGHT ANTHONY R , GAO YI , STEWART KENT D , LONGENECKER KENTON L , ROCKWAY TODD W , MOTTER CHRISTOPHER E , TUFANO MICHAEL D , LIU DACHUN , ZHANG GEOFF G Z , LOU XIAOCHUN , SARRIS KATHY , CHEN SHUANG , KATI WARREN M , LIU YAYA , FRANCZYK THADDEUS S II , HENGEVELD JOHN E
IPC: C07D239/22 , A61K31/513 , A61P31/12 , C07D239/54 , C07D401/10 , C07D403/10 , C07D409/10 , C07D413/10 , C07D417/10
Abstract: Esta invención se relaciona con: (a) compuestos y sales de los mismos que, entre otros, inhiben el HCV; (b) intermediarios de utilidad para la preparación de dichos compuestos y sales; (c) composiciones que comprenden tales compuestos y sales; (d) métodos para preparar tales intermediarios, compuestos, sales y composiciones; (e) métodos de uso de tales compuestos, sales y composiciones; y (f) conjuntos de elementos que comprenden tales compuestos, sales y composiciones.
-
公开(公告)号:CA2740195A1
公开(公告)日:2010-07-01
申请号:CA2740195
申请日:2009-12-22
Applicant: ABBOTT LAB
Inventor: DEGOEY DAVID A , DONNER PAMELA L , KATI WARREN M , HUTCHINS CHARLES W , KRUEGER ALLAN C , RANDOLPH JOHN T , MOTTER CHRISTOPHER E , KRISHNAN PREETHI , MISTRY NEETA C , PILOT-MATIAS TAMI J , PATEL SACHIN V , LI XIAOYAN , SOLTWEDEL TODD N , NELSON LISSA T
IPC: C07D471/04 , A61K31/4375 , A61K31/519 , A61P31/14
Abstract: Compounds effective in inhibiting replication of Hepatitis C virus ("HCV") are described. This invention also relates to processes of making such compounds, compositions comprising such compounds, and methods of using such compounds to treat HCV infection.
-
公开(公告)号:BRPI0620440A2
公开(公告)日:2010-06-29
申请号:BRPI0620440
申请日:2006-12-20
Applicant: ABBOTT LAB
Inventor: BETEBENNER DAVID A , DEGOEY DAVID A , MARING CLARENCE J , KRUEGER ALLAN C , IWASAKI NOBUHIKO , ROCKWAY TODD W , ANDERSON DAVID D , DONNER PAMELA L , GREEN BRIAN E , KEMPF DALE J , LIU DACHUN , MCDANIEL KEITH F , MADIGAN DAROLD , MOTTER CHRISTOPHER E , PRATT JOHN K , SHANLEY JASON P , TUFANO MICHAEL D , WAGNER ROLF , ZHANG RONG , MOLLA AKHTERUZZAMAN , MO HONGMEI , PILOT-MATIAS TAMI J , MASSE SHERIE VL , CARRICK ROBERT J , HE WEPING , LU LIANGJUN , GRAMPOVNIK DAVID J , COOPER CURT S
IPC: C07D471/04
-
公开(公告)号:CA2699986A1
公开(公告)日:2009-03-26
申请号:CA2699986
申请日:2008-09-17
Applicant: ABBOTT LAB
Inventor: FLENTGE CHARLES A , HUTCHINSON DOUGLAS K , BETEBENNER DAVID A , DEGOEY DAVID A , DONNER PAMELA L , KATI WARREN M , KRUEGER ALLAN C , LIU DACHUN , LIU YAYA , LONGENECKER KENTON L , MARING CLARENCE J , MOTTER CHRISTOPHER E , PRATT JOHN K , RANDOLPH JOHN T , ROCKWAY TODD W , STEWART KENT D , WAGNER ROLF , BARNES DAVID M , CHEN SHUANG , FRANCZYK THADDEUS S II , GAO YI , HAIGHT ANTHONY R , HENGEVELD JOHN E , KOTECKI BRIAN J , LOU XIAOCHUN , ZHANG GEOFF G Z
IPC: C07D239/22 , A61K31/513 , A61P31/12 , C07D239/54 , C07D401/10 , C07D403/10 , C07D405/10 , C07D409/10 , C07D413/10 , C07D417/10
Abstract: This invention relates to: (a) compounds and salts thereof that, inter alia, inhibit HCV; (b) intermediates useful for the preparation of such compounds and salts; (c) compositions comprising such compounds and salts; (d) methods for preparing such intermediates, compounds, salts, and compositions; (e) methods of use of such compounds, salts, and compositions; and (f) kits comprising such compounds, salts, and compositions.
-
公开(公告)号:CA2633757A1
公开(公告)日:2007-07-05
申请号:CA2633757
申请日:2006-12-20
Applicant: ABBOTT LAB
Inventor: KRUEGER ALLAN C , DEGOEY DAVID A , MARING CLARENCE J , ROCKWAY TODD W , WAGNER ROLF , ANDERSON DAVID D , IWASAKI NOBUHIKO , DONNER PAMELA L , ZHANG RONG , HE WEPING , MOTTER CHRISTOPHER E , GRAMPOVNIK DAVID J , MOLLA AKHTERUZZAMAN , LU LIANGJUN , BETEBENNER DAVID A , GREEN BRIAN E , CARRICK ROBERT J , COOPER CURT S , KEMPF DALE J , PILOT-MATIAS TAMI J , LIU DACHUN , MO HONGMEI , SHANLEY JASON P , MASSE SHERIE VL , MADIGAN DAROLD L , MCDANIEL KEITH F , PRATT JOHN K , TUFANO MICHAEL D
IPC: C07D471/04
Abstract: Compounds effective in inhibiting replication of Hepatitis C virus (“HCV”) or other viruses are disclosed. This invention is also directed to compositions comprising such compounds, co-formulation or co-administration of such compounds with other anti-viral or therapeutic agents, processes and intermediates for the syntheses of such compounds, and methods of using such compounds for the treatment of HCV or other viral infections.
-
公开(公告)号:AU2006330924A1
公开(公告)日:2007-07-05
申请号:AU2006330924
申请日:2006-12-20
Applicant: ABBOTT LAB
Inventor: KEMPF DALE J , WAGNER ROLF , KRUEGER ALLAN C , GREEN BRIAN E , PILOT-MATIAS TAMI J , ANDERSON DAVID D , GRAMPOVNIK DAVID J , PRATT JOHN K , MCDANIEL KEITH F , MARING CLARENCE J , MOTTER CHRISTOPHER E , MADIGAN DAROLD L , LU LIANGJUN , TUFANO MICHAEL D , ZHANG RONG , MASSE SHERIE VL , HE WEPING , MOLLA AKHTERUZZAMAN , MO HONGMEI , SHANLEY JASON P , COOPER CURT S , CARRICK ROBERT J , ROCKWAY TODD W , LIU DACHUN , DONNER PAMELA L , IWASAKI NOBUHIKO , DEGOEY DAVID A , BETEBENNER DAVID A
IPC: C07D471/04
Abstract: Compounds effective in inhibiting replication of Hepatitis C virus (“HCV”) or other viruses are disclosed. This invention is also directed to compositions comprising such compounds, co-formulation or co-administration of such compounds with other anti-viral or therapeutic agents, processes and intermediates for the syntheses of such compounds, and methods of using such compounds for the treatment of HCV or other viral infections.
-
公开(公告)号:CA2571726A1
公开(公告)日:2006-02-09
申请号:CA2571726
申请日:2005-06-29
Applicant: ABBOTT LAB
Inventor: FLOSI WILLIAM J , GRAMPOVNIK DAVID J , KLEIN LARRY L , DEGOEY DAVID A , KEMPF DALE J , WANG XIU C
IPC: C07F9/09 , A61K31/661 , A61P35/00
Abstract: A compound of the formula I, II or III is disclosed as a prodrug of an HIV protease inhibitor. Methods and compositions of inhibiting HIV protease activity and treating HIV infection are also disclosed.
-
110.
公开(公告)号:HU0101224A2
公开(公告)日:2001-08-28
申请号:HU0101224
申请日:1999-04-12
Applicant: ABBOTT LAB
Inventor: CHEN HUI-JU , CHEN YUANWEI , DEGOEY DAVID A , FLOSI WILLIAM J , GIRANDA VINCENT L , GRAMPOVNIK DAVID J , GU YU-GUI , KATI WARREN M , KEMPF DALE J , KENNEDY APRIL , KLEIN LARRY L , KRUEGER ALLAN C , LIN ZHEN , MADIGAN DAROLD L , MARING CLARENCE J , MCDANIEL KEITH F , MUCHMORE STEVEN W , SHAM HING L , STEWART KENT D , STOLL VINCENT S , SUN MINGHUA , WANG GARY T , WANG SHELDON , XU YIBO , YEUNG MING C , ZHAO CHEN
IPC: A61K31/401 , A61K31/4025 , A61K31/41 , A61K31/4155 , A61K31/4178 , A61K31/422 , A61K31/4245 , A61K31/427 , A61K31/433 , A61K31/5377 , A61P31/16 , A61P43/00 , C07D207/16 , C07D207/32 , C07D207/325 , C07D207/327 , C07D401/12 , C07D403/04 , C07D403/06 , C07D405/04 , C07D405/06 , C07D405/14 , C07D409/04 , C07D409/06 , C07D409/14 , C07D413/04 , C07D413/14 , C07D417/04 , C07D417/06 , C07D521/00 , C07F9/572
-
-
-
-
-
-
-
-
-